SYMPOSIUM

2026

  • eadv.org
EADV Logo

About the EADV Spring Symposium

Every year, the EADV Spring Symposium provides an exceptional opportunity for networking, bringing together healthcare professionals passionate about advancing their expertise and careers at a leading European event dedicated to skin and venereal health.

The venue
Accommodation

Letter from the President

Dear Colleagues, Dear Friends,
As President of the EADV, I am honoured to welcome you to the European Academy of Dermatology and Venereology (EADV) Spring Symposium, taking place in Prague from May 22nd – 24th 2025.
Spring Symposia hold a special place in the EADV calendar, emphasizing our continued commitment to European inclusiveness and allowing for an in-depth exploration of specific topics. For this much-anticipated event, we’ve chosen the Bohemian backdrop of Prague.
In Prague participants can expect to explore a rich programme curated by the Scientific Programming Committee with scientific content specifically focussing on viral infections and on new targeted treatments for inflammatory diseases. Moreover, “What’s new” sessions will cover the latest updates in the main fields of dermatology and venereology, such as skin cancer, psoriasis, STIs, hidradenitis suppurativa and lupus.
This year an increased number of “interactive clinical cases” sessions will offer a greater opportunity for the audience to actively participate to the delivery of the scientific content. “Free Communications” sessions will present the best valued abstracts from a vast number of submissions.
The anticipated Plenary lecture will be delivered by Professor Bohdan Pomahac, from Yale University who will intrigue us with the ‘many faces’ of full-face transplantation.
You are warmly invited to join us in the city of a Hundred Spires, where the union of knowledge and participation will create an unforgettable experience.

Uvidíme se v Praze!

Prof. Branka Marinovic
EADV President

First plenary lecture and networking symposium

A welcome address from the EADV President, Prof. Branka Marinović, will officially kick off the 2025 EADV Symposium on Thursday, 22 May 2025.

Following her remarks, Prof. Bohdan Pomahac will deliver the first plenary lecture of this year’s Symposium on the groundbreaking field of face transplantation.

To conclude the evening, join us for a networking reception to celebrate the start of the 2025 EADV Symposium and connect with colleagues and speakers in a relaxed setting.

17:30
Opening plenary lecture

Forum hall – Level 2

18:30
Networking reception

Level 2

EADV Networking delegates

Healthcare Professional definition

  1. Important note to Healthcare and Non-Healthcare Professionals

    Access to the different areas and sessions of the Symposium is determined by the attendee’s Healthcare Professional status.

    As a multidisciplinary audience will attend the EADV Congress, the EADV will assign different classes to Healthcare Professionals (HCPs) and Non-Healthcare Professionals (non-HCPs) to ensure compliance with the Hellenic Association of Pharmaceutical Companies (SFEE’s Promotion Code) (CODE OF ETHICS & PARTNERSHIPS | SFEE).
    Please read the description below to ensure that you (or your delegates) comply with the regulations in place.

EADV members are not automatically considered Healthcare Professionals

Please select the correct status (HCP or non-HCP) during registration.

  1. Definition The SFEE code defines Healthcare Professionals as follows (Definitions, page 6):“any natural person who is identified as a healthcare professional in the applicable legislation1 and whose primary practice or principal professional address is in Greece and who, in the course of his/her professional activities, may prescribe, purchase, supply, recommend or administer medicinal products.

    It is explicitly clarified that the very broad subset of Healthcare Professionals who are not legally entitled to prescribe, supply or administer medicinal products, but nevertheless belong to the category of Healthcare Professionals, are not considered as general public. In this sense, product promotions at scientific event venues where such persons may be present are no prohibited.

    In the context of the national cancer policy, the specialty of pathologists is also explicitly included in this definition.

    To avoid any doubt, the term“Healthcare Professional”, with the exception of Chapter 1

    hereof, also includes:

    1. any official or employee of a government agency or other organisation (whether in the public or private sector) who may prescribe, purchase, supply, recommend or administer Medicinal Products; and
    2. any employee of a Pharmaceutical Company whose primary occupation is that of a practising HCP (e.g. medical doctor, nurse, dentist, etc.).
    However, the definition excludes:
    • all other full-term personnel (whether HCPs or not) of a PC under an employment contract, professional service contract or independent work contract; and
    • wholesalers or distributors of Medicinal Products.”

    Article 4 of Law 4238/GG A, 38/17.02.2014, characterises the following persons as Healthcare Professionals (HCPs): family physicians and physicians of other specialties, dentists and other healthcare professionals such as midwives, health visitors, nurses, social workers, physiotherapists, dieticians/nutritionists, psychologists, occupational therapists, medical laboratory technologists, medical and biological laboratory assistants, medical equipment operators.

    Medical students are not considered Healthcare Professionals under the current guidelines and will be automatically classified as Non-Healthcare Professionals.

  1. Industry sessions

    Satellite Symposia presenting data on the development, research, or other issues related to prescription medicine is restricted to Healthcare Professionals and Non Member (INDUSTRY) as indicated by the Industry Session Organizer.
    All promotional materials and marketing aids related to these industry sessions should be strictly limited to HCPs.

    Industry Session organisers can limit participation to certain representative groups independently from the EADV recommendations if deemed imperative to achieving the session’s intended purpose. The organising company reserves the right to refuse single categories, particularly if they are not adequately related to the session’s objective and purpose.

    The industry session organiser is responsible for compliance with the session